Radiolabeled PSMA Inhibitors

SIMPLE SUMMARY: Prostate cancer remains one of the leading causes of cancer death in men worldwide. Despite the recent success in the development and clinical application of radiopharmaceuticals targeting the prostate-specific membrane antigen (PSMA) for diagnosis and endoradiotherapy of prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Neels, Oliver C., Kopka, Klaus, Liolios, Christos, Afshar-Oromieh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699044/
https://www.ncbi.nlm.nih.gov/pubmed/34944875
http://dx.doi.org/10.3390/cancers13246255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699044/
https://www.ncbi.nlm.nih.gov/pubmed/34944875
http://dx.doi.org/10.3390/cancers13246255

Ejemplares similares